BIOCONNSEBiocon Limited· PharmaceuticalsHighNeutral
Announced Thu, 19 Jun · 19:51 IST

Biocon Limited has informed the Exchange about Qualified Institutions Placement

Qip At DiscountFund Raising View source PDF

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Biocon Limited has closed its Qualified Institutions Placement (QIP) on June 19, 2025, which opened on June 16, 2025. The company allocated 13,63,63,635 equity shares to eligible qualified institutional buyers at ₹330 per share, raising approximately ₹4,500 crore. The issue price was set at a discount of ₹10.20 (3%) to the floor price of ₹340.20 per share. The shares have a face value of ₹5 each, with the issue price including a premium of ₹325 per share. The Fund Raising Committee approved the closure, allocation, and confirmation note during a meeting held on June 19, 2025.

Likely market impact

Biocon has successfully raised around ₹4,500 crore through the QIP, strengthening its capital base. However, allotting shares at a 3% discount to the floor price means existing shareholders face some dilution at below-market reference levels, which may exert mild short-term pressure on the stock price.